NCT01667744

Citalopram for Sx/Util in Acute Coronary Syndrome Patients

• Status: Withdrawn
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Henry Ford Health System · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Symptoms (chest pain, shortness of breath, dizziness, etc.) and treatment usage (doctor or emergency room visits, testing, hospital days, etc.) in patients with Acute Coronary Syndromes are known to be related to emotional distress (Anxiety, Depression and Anger). In addition, behavioral treatment of emotional distress is known to decrease symptoms, and treatment usage. The present protocol tests whether the addition of a medication known to reduce emotional distress can also reduce symptoms and treatment usage. This will done by recruiting patients with ACS during their hospital stay, randomizing them to receive citalopram or placebo, and then examining their symptoms and treatment usage at 6 months.

Detailed description

Not applicable. Study not funded.

Conditions

• Acute Coronary Syndrome

Interventions

Type	Name	Description
DRUG	Citalopram	10 mg/day

Timeline

• Start date: 2016-01-01
• Primary completion: 2016-02-01
• Completion: 2021-02-16
• First posted: 2012-08-17
• Last updated: 2022-12-09

Locations

1 site across 1 country: United States